Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2582)
All Articles published online
|
Apr 15, 1998 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao XY, Yu SY, Da SP, Bai L, Guo XZ, Dai XJ, Wang YM. A clinical evaluation of serological diagnosis for pancreatic cancer. World J Gastroenterol 1998; 4(2): 147-149 [PMID: 11819260 DOI: 10.3748/wjg.v4.i2.147] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v4/i2/147.htm |
| Number | Citing Articles |
| 1 |
Dong WU, Jia Ming QIAN, Rui Xue DENG, Wei Jun JIANG, Yuan Jia CHEN, Xiao Hong LIU, Xing Hua LU. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer. Chinese Journal of Digestive Diseases 2006; 7(2): 117 doi: 10.1111/j.1443-9573.2006.00249.x
|
| 2 |
Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Min Lu, Lin Wang, Quan-Ru He. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World Journal of Gastroenterology 2004; 10(3): 427-432 doi: 10.3748/wjg.v10.i3.427
|
| 3 |
Jonathan M. Oyler, Bao Q. Tran, David P. A. Kilgour. Rapid Denaturing Organic Digestion Method for Targeted Protein Identification and Characterization. Analytical Chemistry 2021; 93(12): 5046 doi: 10.1021/acs.analchem.0c04143
|
| 4 |
Tsann‐Long Hwang, Ying Liang, Kuan‐Yi Chien, Jau‐Song Yu. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. PROTEOMICS 2006; 6(7): 2259 doi: 10.1002/pmic.200500345
|
| 5 |
Antonio Moral, José Magarzo. Marcadores tumorales serológicos en cirugía hepatobiliopancreática. Cirugía Española 2004; 76(5): 276 doi: 10.1016/S0009-739X(04)72378-7
|
| 6 |
George Vasiliades, Nikolaos Kopanakis, Michalis Vasiloglou, George Zografos, Helias Margaris, Kyriaki Masselou, Evniki Kokosi, Theodore Liakakos. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer. The International Journal of Biological Markers 2012; 27(3): 186 doi: 10.5301/JBM.2012.9348
|
| 7 |
Jun-Ming Guo, Bing-Xiu Xiao, De-Jian Dai, Qiong Liu, Hong-Hui Ma. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells <i>in vitro</i>. World Journal of Gastroenterology 2004; 10(6): 860-863 doi: 10.3748/wjg.v10.i6.860
|
| 8 |
Lane C. Patten, David H. Berger. Role of Proteases in Pancreatic Carcinoma. World Journal of Surgery 2005; 29(3): 258 doi: 10.1007/s00268-004-7816-3
|
| 9 |
Felix Rückert, Christian Pilarsky, Robert Grützmann. Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries. Cancers 2010; 2(2): 1107 doi: 10.3390/cancers2021107
|
| 10 |
E. Coban, M. Samur, H. Bozcuk, M. Ozdogan. The Value of CEA and CA 19-9 in Detecting Cancer in a Group of High-Risk Subjects with Gastrointestinal Symptoms. The International Journal of Biological Markers 2003; 18(3): 177 doi: 10.1177/172460080301800304
|
| 11 |
Jiehua Lin, Feng Yan, Xiaoya Hu, Huangxian Ju. Chemiluminescent immunosensor for CA19-9 based on antigen immobilization on a cross-linked chitosan membrane. Journal of Immunological Methods 2004; 291(1-2): 165 doi: 10.1016/j.jim.2004.06.001
|
| 12 |
X.G. Ni, X.F. Bai, Y.L. Mao, Y.F. Shao, J.X. Wu, Y. Shan, C.F. Wang, J. Wang, Y.T. Tian, Q. Liu, D.K. Xu, P. Zhao. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 2005; 31(2): 164 doi: 10.1016/j.ejso.2004.09.007
|
| 13 |
Mohamed M. Abdel-Aziz, Mahmoud Lotfy, Ibrahim M. El-Kady, Mostafa Abozaid. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor. Cancer Detection and Prevention 2009; 32(4): 329 doi: 10.1016/j.cdp.2005.10.006
|
| 14 |
Fangfeng Liu, Futian Du, Xiao Chen. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-333
|
| 15 |
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, Chun-Chieh Yeh, Chao-Ming Tseng, Wen-Hsin Huang, Teng-Yu Lee, Chia-Shen Chu, Jaw-Town Lin. Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma. Journal of the Formosan Medical Association 2022; 121(12): 2601 doi: 10.1016/j.jfma.2022.07.003
|
| 16 |
Yang Tang, Yidi Cui, Shufeng Zhang, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162: 121 doi: 10.1016/bs.pmbts.2019.01.010
|
| 17 |
B.C. Visser, V.R. Muthusamy, B.M. Yeh, F.V. Coakley, L.W. Way. Diagnostic evaluation of cystic pancreatic lesions. HPB 2008; 10(1): 63 doi: 10.1080/13651820701883155
|
| 18 |
Chao-Xu Zheng, Wen-Hua Zhan, Ji-Zong Zhao, Dong Zheng, Dong-Ping Wang, Yu-Long He, Zhang-Qing Zheng. Prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World Journal of Gastroenterology 2001; 7(3): 431-434 doi: 10.3748/wjg.v7.i3.431
|
| 19 |
Min Zheng, Lian-Xin Liu, An-Long Zhu, Shu-Yi Qi, Hong-Chi Jiang, Zhu-Ying Xiao. <i>K-ras</i> gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses. World Journal of Gastroenterology 2003; 9(1): 188-191 doi: 10.3748/wjg.v9.i1.188
|
| 20 |
Xiaozhong Guo, Zhongmin Cui. Current Diagnosis and Treatment of Pancreatic Cancer in China. Pancreas 2005; 31(1): 13 doi: 10.1097/01.mpa.0000168220.97967.d1
|
| 21 |
Jens Koopmann, C. Nicole White Rosenzweig, Zhen Zhang, Marcia I. Canto, David A. Brown, Mark Hunter, Charles Yeo, Daniel W. Chan, Samuel N. Breit, Michael Goggins. Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9. Clinical Cancer Research 2006; 12(2): 442 doi: 10.1158/1078-0432.CCR-05-0564
|
| 22 |
MASAHIRO TANAKA, NOBUKAZU KOMATSU, YASUAKI YANAGIMOTO, MASAO OKA, SHIGEKI SHICHIJO, SEIYA OKUDA, KYOGO ITOH. Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes. The Kurume Medical Journal 2006; 53(3/4): 63 doi: 10.2739/kurumemedj.53.63
|
| 23 |
Chunlin Ge, Ning Ma, Dianbo Yao, Fengming Luan, Chaojun Hu, Yongzhe Li, Yongfeng Liu. A serum Biomarker model to diagnose pancreatic cancer using proteomic fingerprint technology. Chinese Journal of Clinical Oncology 2008; 5(3): 200 doi: 10.1007/s11805-008-0200-6
|
| 24 |
Min-Pei Liu, Xiao-Zhong Guo, Jian-Hua Xu, Di Wang, Hong-Yu Li, Zhong-Min Cui, Jia-Jun Zhao, Li-Nan Ren. New tumor-associated antigen SC6 in pancreatic cancer. World Journal of Gastroenterology 2005; 11(48): 7671-7675 doi: 10.3748/wjg.v11.i48.7671
|
| 25 |
Ying-Nai Wang, Heng-Huan Lee, Mien-Chie Hung. A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0484-7
|
| 26 |
Dan Du, Feng Yan, Shengli Liu, Huangxian Ju. Immunological assay for carbohydrate antigen 19-9 using an electrochemical immunosensor and antigen immobilization in titania sol–gel matrix. Journal of Immunological Methods 2003; 283(1-2): 67 doi: 10.1016/j.jim.2003.08.014
|
| 27 |
Ning Ma, Chun-lin Ge, Feng-ming Luan, Dian-bo Yao, Chao-jun Hu, Ning Li, Yong-feng Liu. Serum protein fingerprint of patients with pancreatic cancer by SELDI technology. Chinese Journal of Cancer Research 2008; 20(3): 171 doi: 10.1007/S11670-008-0171-4
|